<?xml version="1.0" encoding="UTF-8"?>



<records>

  <record>
    <language>eng</language>
          <publisher>Oriental Scientific Publishing Company</publisher>
        <journalTitle>Biomedical and Pharmacology Journal</journalTitle>
          <issn>0974-6242</issn>
            <publicationDate>2021-09-30</publicationDate>
    
        <volume>14</volume>
        <issue>3</issue>

 
    <startPage>1707</startPage>
    <endPage>1720</endPage>

	 
      <doi>10.13005/bpj/2272</doi>
        <publisherRecordId>41024</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">Dinoxin B Withanolide from Datura inoxia Mill as an Effective Phytocompound Against Urinary Tract Infection causing  Staphylococcus aureus</title>

    <authors>
	 


      <author>
       <name>Ruby George</name>

 
		
	<affiliationId>1</affiliationId>
      </author>
    

	 


      <author>
       <name>Priti Mathur</name>


		
	<affiliationId>1</affiliationId>

      </author>
    

	 


      <author>
       <name>Chandni Tandon</name>

		
	<affiliationId>2</affiliationId>
      </author>
    

	


	


	
    </authors>
    
	    <affiliationsList>
	    
		
		<affiliationName affiliationId="1">Amity Institute of Biotechnology, Amity University Uttar Pradesh,  Lucknow, India – 226 028</affiliationName>
    

		
		<affiliationName affiliationId="2">Patanjali Research Institute, Haridwar, Uttarakhand, India  249405</affiliationName>
    
		
		
		
		
	  </affiliationsList>






    <abstract language="eng">Background: Dinoxin B Withanolide was isolated from Datura inoxia and identified with its cytotoxic activity. But its antibacterial properties are not yet evaluated. We have previously reported the broad-spectrum antibacterial property of Dinoxin B Withanolide extracted from <em>D.inoxia</em> on standard strains.

Objective: This research has focused to evaluate the efficacy of Dinoxin B Withanolide against infectious <em>Staphylococcus</em> <em>aureus</em>, including resistant strains.

Methods: Electrospray Ionization-Mass Spectrometry is used to depict the presence of Dinoxin B withanolide from the chromatographic ethanolic leaf fraction. Antibacterial activity of different concentrations of  Dinoxin B(12500-100000 μg/ml) was assessed using the agar diffusion, macro broth dilution, and time-kill assay methods. Docking studies and Drug likeness properties were analyzed.

Result: Electrospray Ionization-Mass Spectrometry depicted the presence of Dinoxin B. All the isolates were susceptible to Dinoxin B within the range of 15±0.5mm to 24±0.5mm, and the bacteria were susceptible at a concentration rate of ≤12.5mg/ml. Time-kill assay showed that 25mg/ml of Dinoxin B displayed the highest inhibitory activity after four hours. The MBC values were compatible with the cidal concentration as seen in the time-kill study's growth curve. Computer-aided techniques resulted in a good  Docking score towards Quorum-signaling Sar A protein (-7.82)and Penicillin Binding Protein(-6.9).

Conclusion: Dinoxin B with its bactericidal properties and significant affinity towards<strong>  </strong>Quorum-signaling Sar A protein and Penicillin Binding Protein can be considered as an effective bioactive compound against Methicillin Resistance <em>Staphylococcus</em> <em>aureus.</em></abstract>

    <fullTextUrl format="html">https://biomedpharmajournal.org/vol14no3/dinoxin-b-withanolide-from-datura-inoxia-mill-as-an-effective-phytocompound-against-urinary-tract-infection-causing-staphylococcus-aureus/</fullTextUrl>

<keywords language="eng">

      
        <keyword>Antibacterial activity</keyword>
      

      
        <keyword> Datura inoxia</keyword>
      

      
        <keyword> Dinoxin B Withanolide</keyword>
      

      
        <keyword> Molecular docking</keyword>
      

      
        <keyword> Methicillin-Resistant</keyword>
      

      
        <keyword> Staphylococcus aureus</keyword>
      
</keywords>
  </record>
</records>